We invite the participants to submit their applications. Documents, required to be submitted to participate in the procedures, can be found following the link https://cutt.ly/EQXseId Negotiation procedures will be applied to procure items on the tuberculosis.
SE “MPU” plans to negotiate on the following subjects of procurement:
Nomenclature position |
ID of procurement |
Units |
Quantity |
Expected purchase price, UAH |
|
Ізоніазид ампули, флакони, шприци 100 мг/мл |
UA-2021-06-10-012281-b UA-2021-07-12-010271-c |
ампули, флакони, шприци |
13 967 |
36 453,87 |
|
Рифампіцин 150 мг |
UA-2021-06-10-011999-b UA-2021-07-12-008392-c |
таблетки, капсули, драже (у стрипах, блістерах або у контурній чарунковій упаковці) |
1 220 136 |
1 085 921,04 |
|
Рифапентин таблетки, капсули, драже 150 мг |
UA-2021-06-10-011878-b; UA-2021-07-12-010194-c |
таблетки, капсули, драже |
178 260 |
843 169,80 |
|
Рифабутин таблетки, капсули, драже 150 мг |
UA-2021-06-10-011988-b UA-2021-07-12-010050-c |
таблетки, капсули, драже (у стрипах, блістерах або у контурній чарунковій упаковці) |
17 295 |
551 883,45 |
|
Піразинамід таблетки, капсули, драже 500 мг |
UA-2021-06-10-011598-b UA-2021-07-12-009986-c |
таблетки, капсули, драже (у стрипах, блістерах або у контурній чарунковій упаковці) |
156 406 |
86 023,30 |
|
Етамбутол дисперговані таблетки 100 мг |
UA-2021-06-10-012007-b UA-2021-07-12-007890-c |
таблетки (у стрипах, блістерах або у контурній чарунковій упаковці) |
48 728 |
413 700,72 |
|
Етамбутол ампули, флакони, шприци 100 мг/мл |
UA-2021-06-10-012189-b UA-2021-07-12-010265-c |
ампули, флакони, шприци (по 20 мл) |
11 743 |
868 864,57 |
|
Рифампіцин/ізоніазид дисперговані таблетки 75 мг/50 мг |
UA-2021-06-10-011979-b; UA-2021-07-12-010181-c |
таблетки (у стрипах, блістерах або у контурній чарунковій упаковці) |
46 554 |
79 141,80 |
|
Рифапентин/ізоніазид таблетки, капсули, драже 300 мг/300 мг |
UA-2021-06-10-011873-b UA-2021-07-12-009976-c |
таблетки, капсули, драже |
39 776 |
1 097 022,08 |
|
Рифампіцин/ізоніазид/ піразинамід дисперговані таблетки 75 мг/50 мг/ 150 мг |
UA-2021-06-10-012065-b UA-2021-07-12-010262-c |
таблетки (у стрипах, блістерах або у контурній чарунковій упаковці) |
30 222 |
61 235,82 |
|
Протіонамід таблетки, капсули, драже 250 мг |
UA-2021-06-10-011855-b UA-2021-07-12-009214-c |
таблетки, капсули, драже (у стрипах, блістерах або у контурній чарунковій упаковці) |
41 588 |
128 506,92 |
|
Клофазимін таблетки, капсули, драже 100 мг |
UA-2021-06-10-011926-b UA-2021-07-12-010076-c |
таблетки, капсули, драже |
208 003 |
2 762 279,84 |
|
Амоксицилін з клавулановою кислотою таблетки, капсули, драже 500 мг/125 мг |
UA-2021-06-10-005739-b UA-2021-07-12-010037-c |
таблетки, капсули, драже (у стрипах, блістерах або у контурній чарунковій упаковці) |
68 493 |
191 095,47 |
|
Амоксицилін з клавулановою кислотою ампули, флакони, шприци 1000 мг/200 мг |
UA-2021-06-10-012040-b UA-2021-07-12-010251-c |
ампули, флакони, шприци |
1 900 |
57 760,00 |
|
Бедаквілін таблетки, капсули, драже 100 мг |
UA-2021-06-10-006756-b UA-2021-07-12-010079-c |
таблетки, капсули, драже |
120721 |
4 570 997,92 |
|
Циклосерин таблетки, капсули, драже 250 мг |
UA-2021-06-10-009104-b UA-2021-07-13-003919-c |
таблетки, капсули, драже (у стрипах, блістерах або у контурній чарунковій упаковці) |
106 686 |
523 828,26 |
|
Меропенем ампули, флакони, шприци 1000 мг |
UA-2021-06-10-007604-b UA-2021-07-13-007019-c |
ампули, флакони, шприци |
20 030 |
1 125 085,10 |
|
Information about procurement: |
|||||
Place of delivery |
Address of delivery (warehouse in Kyiv or Kyiv Region) is determined by the customer at the moment when the customer gives a confirmation of goods delivery to the supplier. |
||||
Time of goods delivery |
Till December 1st, 2021 including.
|
||||
Information about currency of price in commercial offer |
The currency of the commercial offer is hryvnia. (UAH). The offer price of the resident participant is formed on the basis of the DAP delivery basis (Incoterms-2020) taking into account all costs, taxes and fees to be paid and all other costs associated with the supply of goods. The participant takes on its own expenses all the costs for obtaining the necessary permits and licenses. Non-resident participants can determine the offer price on the terms of delivery DAP (Incoterms-2020) in US dollars (USD, currency code 840) or Euro (EUR, currency code 978). |
||||
Information about language (languages) of tender offer |
All documents related to the offer and prepared directly by the bidder must be drawn up in Ukrainian, and documents issued by other institutions may be submitted by the bidder as part of the bid in Ukrainian or another language. If the offer includes a document drawn up in language other than Ukrainian, the bidder must provide an authentic translation of such a document into Ukrainian. The text in Ukrainian is decisive. The translation must be signed or certified by a person authorized to sign the offer and may be certified by the participant's seal, if used.
|
A bidder whose products meet the required characteristics listed in the relevant Annex 1 and who will provide the documents listed in Annexes 2, 2a and 2b, and whose commercial offer will be the most cost-effective will be invited to participate in the negotiation procedure. Аdditionally, we would like to inform you that the bidder, who will be determined as the winner of the negotiated procurement procedure, must provide SE “MPU” with documents confirming the absence of grounds specified in paragraphs 2, 3, 5, 6, 8, 12 and 13 of part one and part two of Article 17 Of the Law.
We kindly ask you to send the list of documents which contains a commercial offer and documents, by 12:00 (GMT +3) August 25th 2021 to the e-mail address of SE “MPU”: This email address is being protected from spambots. You need JavaScript enabled to view it., copied to: This email address is being protected from spambots. You need JavaScript enabled to view it., This email address is being protected from spambots. You need JavaScript enabled to view it.. The documents can be found following the link https://cutt.ly/EQXseId.
We would like to inform you that the provision of an offer does not create any advantages for the market participant during procurement and does not impose any obligations on SE “Medical Procurement of Ukraine” in relation to the market participant.